NCT01536522Enrolling by invitationEarly phase 1
Asthma Inflammation Research
Source: ClinicalTrials.gov · Last updated 28 May 2026
Brief summary (registry, in English)
The overall goal of the Asthma Inflammation Research \[AIR\] Translational Program is to create an integrated multidisciplinary team for the focused purpose of development of diagnostic and prognostic tests informative for airway inflammation, and for the design of innovative, targeted biologic therapeutics. The overarching aims of the AIR program are to conceptualize, develop, and test the next-generation therapeutics, and novel asthma diagnostic and prognostic tools that will allow us to improve the standard of asthma care.
- Status (registry)
- Enrolling by invitation
- Phase (registry)
- Early phase 1
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 13 Feb 2012
- Start date
- Jan 2011
- Primary completion date
- Jun 2027
- Lead sponsor
- The Cleveland Clinic
- Diseases
- Asthma
- NCT number
- NCT01536522
What you commit to
- Study type: Interventional · Early phase 1
- Planned participants: 60
- From Jan 2011 to the primary completion date, Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any milk allergies
- Coconut allergies
- Current smoking or smoking history of greater than 10 pack-years
- Any other significant respiratory or cardiac disease or the presence of clinically important comorbidities, including, uncontrolled coronary artery disease, acute or and chronic renal failure
Lab values
- Diabetes (fasting blood sugar \>110 mg/dL)
Other
- BMI \>40 kg/m2,
- Inability to maintain diet intervention
Who the study is looking for
- Asthma diagnosed by a medical specialist and/or history of positive methacholine rest and/or reversibility of \>10% of FEV1
- FEV1 is within acceptable limits
- Informed Consent is present
Age in the registry: 18 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cleveland Clinic Coordinator of this site? Confirm its status | Cleveland | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.